← Eichor
Study identifier: NCT04571918 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer.

Condition: Massive Rotator Cuff Tears  ·  Sponsor: Oslo University Hospital

PhaseNA
Planned participants50
Who can joinAll sexes, 60 Years to 85 Years
Healthy volunteersNo

About this study

Massive rotator cuff tears are common in the adult population. It is estimated that about 12 % of adults 60 years of age or older suffer from a rotator cuff injury. About 40 % of these injuries are classified as massive rotator cuff tears (MRCT). MRCT propose a great challenge to the affected patient and its doctor. It is a painful condition with few treatment options. The study aims to investigate the operative treatment for MRCT with the new treatment option proposed by Senecovic. Insertion of a biodegradable balloon as a subacromial spacer has proven promising results so far. To this date there is only small and non-randomized studies on the subject. AMRIS are planning to do a randomized controlled study where group A is treated with arthroscopic debridement, biceps tenotomy and biodegradable spacer, while group B, the control group are treated with arthroscopic debridement and biceps tenotomy.

This description comes directly from the study's public registry record.

Talk to the study team

Hannah Ugletveit Jahr, Cand. med.  ·  +47 90762377  ·  hannah.jahr@gmail.com

Berte Bøe, PhD  ·  +47 41338451  ·  uxbebm@ous-hf.no

Always discuss trial participation with your own doctor first.

Locations (2)

Hospital of Southern Norway, ArendalArendal, NorwayRecruiting
Oslo university hospitalOslo, NorwayNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04571918